Patents by Inventor Kerstien A. Padgett

Kerstien A. Padgett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6627436
    Abstract: The invention concerns an expression vector that permits expression of genes and fragments thereof in both prokaryotic and mammalian systems. The invention also pertains to derivatives of such vector that contain one or more prokaryotic or eukaryotic (especially mammalian) genes or gene fragments. The invention further pertains to prokaryotic or mammalian cells containing such an expression vector or derivative.
    Type: Grant
    Filed: October 31, 1997
    Date of Patent: September 30, 2003
    Assignee: Stratagene
    Inventors: Joseph A. Sorge, Kerstien A. Padgett
  • Publication number: 20020197642
    Abstract: The invention provides improved techniques for conveniently manipulating polynucleotides of interest without the need to rely upon the presence of naturally occurring restriction sites. Additionally, using the methods and primers of the invention, one may synthesize a polynucleotide of interest in a form which is easily and directionally cloned into a DNA sequence of choice without necessarily introducing extraneous nucleotides in the final polynucleotide product. The methods of the invention employ releasable primers that comprise a recognition site for a releasing enzyme joined to a region for annealing to the polynucleotide template of interest. Polynucleotide sequences of interest are synthesized using one or more synthesis primers, wherein at least one of the primers is a releasable primer. After synthesis, the synthesis product is cleaved by a releasing enzyme.
    Type: Application
    Filed: August 5, 2002
    Publication date: December 26, 2002
    Applicant: Stratagene
    Inventors: Joseph A. Sorge, Kerstien A. Padgett
  • Publication number: 20010031483
    Abstract: The invention provides improved techniques for conveniently manipulating polynucleotides of interest without the need to rely upon the presence of naturally occurring restriction sites. Additionally, using the methods and primers of the invention, one may synthesize a polynucleotide of interest in a form which is easily and directionally cloned into a DNA sequence of choice without necessarily introducing extraneous nucleotides in the final polynucleotide product. The methods of the invention employ releasable primers that comprise a recognition site for a releasing enzyme joined to a region for annealing to the polynucleotide template of interest. Polynucleotide sequences of interest are synthesized using one or more synthesis primers, wherein at least one of the primers is a releasable primer. After synthesis, the synthesis product is cleaved by a releasing enzyme.
    Type: Application
    Filed: February 28, 2001
    Publication date: October 18, 2001
    Applicant: Stratagene
    Inventors: Joseph A. Sorge, Kerstien A. Padgett
  • Publication number: 20010016351
    Abstract: The invention concerns an expression vector that permits expression of genes and fragments thereof in both prokaryotic and mammalian systems. The invention also pertains to derivatives of such vector that contain one or more prokaryotic or eukaryotic (especially mammalian) genes or gene fragments. The invention further pertains to prokaryotic or mammalian cells containing such an expression vector or derivative.
    Type: Application
    Filed: October 31, 1997
    Publication date: August 23, 2001
    Inventors: JOSEPH A. SORGE, KERSTIEN A. PADGETT
  • Patent number: 6261797
    Abstract: The invention provides improved techniques for conveniently manipulating polynucleotides of interest without the need to rely upon the presence of naturally occurring restriction sites. Additionally, using the methods and primers of the invention, one may synthesize a polynucleotide of interest in a form which is easily and directionally cloned into a DNA sequence of choice without necessarily introducing extraneous nucleotides in the final polynucleotide product. The methods of the invention employ releasable primers that comprise a recognition site for a releasing enzyme joined to a region for annealing to the polynucleotide template of interest. Polynucleotide sequences of interest are synthesized using one or more synthesis primers, wherein at least one of the primers is a releasable primer. After synthesis, the synthesis product is cleaved by a releasing enzyme.
    Type: Grant
    Filed: September 13, 1996
    Date of Patent: July 17, 2001
    Assignee: Stratagene
    Inventors: Joseph A. Sorge, Kerstien A. Padgett